

4-(m-Tolylamino)pyridine-3-sulfonamide (CAS 72811-73-5) is a pivotal building block in the North American API intermediates market, primarily utilized for the convergent synthesis of Torsemide, where maintaining a Pharma/API purity 99% is critical for meeting stringent FDA requirements for loop diuretic production. 4-(3-Methylphenyl)aminopyridine-3-sulfonamide serves as a high purity fine chemical increasingly sought by US-based CDMOs who are expanding their custom synthesis services to enhance domestic supply chain resilience amidst ongoing global sourcing shifts. 4-(m-Tolylamino)-3-sulfamoylpyridine also finds niche applications in the development of novel heterocyclic derivatives for general industry use at a purity of 98%, requiring a reliable bulk chemical supplier capable of providing the technical depth and regulatory transparency expected by members of the American Chemical Society. We are an established 4-(m-Tolylamino)pyridine-3-sulfonamide intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-(m-Tolylamino)pyridine-3-sulfonamide COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities


4-(m-Tolylamino)pyridine-3-sulfonamide (CAS 72811-73-5) is a pivotal building block in the North American API intermediates market, primarily utilized for the convergent synthesis of Torsemide, where maintaining a Pharma/API purity 99% is critical for meeting stringent FDA requirements for loop diuretic production. 4-(3-Methylphenyl)aminopyridine-3-sulfonamide serves as a high purity fine chemical increasingly sought by US-based CDMOs who are expanding their custom synthesis services to enhance domestic supply chain resilience amidst ongoing global sourcing shifts. 4-(m-Tolylamino)-3-sulfamoylpyridine also finds niche applications in the development of novel heterocyclic derivatives for gene...
Pharmaceutical
Pharmaceutical Actives & Precursors
Intermediates & Precursors
.7767eb0f.png)

Chemical Properties & Specifications
P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P333+P317, P337+P317, P362+P364, and P501
Skin Sens. 1 (96.4%)
Eye Irrit. 2A (100%)
An important building block and critical intermediate primarily used in the multi-step convergent synthesis of the potent loop diuretic torsemide (torasemide) for the treatment of hypertension and edema
A certified reference material or pharmaceutical secondary standard utilized as torsemide related compound A for analytical testing, impurity profiling, and quality control in pharmaceutical research and development
A functionalized pyridine-3-sulfonamide derivative employed in academic and industrial research for the development of complex heterocyclic molecules and medicinal chemistry applications.
4-(m-Tolylamino) pyridine-3-sulfonamide is a high-purity chemical intermediate primarily used in the synthesis of the loop diuretic Torsemide (Torasemide)
This compound is predominantly used in the pharmaceutical industry for the production of active pharmaceutical ingredients (APIs)
It is slightly soluble in DMSO and methanol and is typically used in the synthesis of solid-dose oral medications or injectable diuretics
Standard specifications include CAS number 72811-73-5, a purity level of ≥98% (HPLC), and availability of documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...